loading

Personal reflections on our journey to transform diabetes care and restore peace of mind.

Mohamed Al-Jaifry, CEO
Signature

Mohamed Al-Jaifry

CEO & Founder

"Our mission is deeply personal. We aren't just building tech; we're building a future where families can sleep without fear."
To our patients, our partners, and the entire diabetes community,

I write to you today with humility and immense excitement about the future we are building together at Jaifry. This journey began from a deeply personal place—living in constant fear of severe hypoglycemia, never knowing when a life-threatening drop might strike, especially during the vulnerable hours of sleep.

That personal experience ignited a fire within me to find a better way. I believed that technology should do more than just monitor—it must protect, it must intervene, and it must be the safety net that catches us when we can't catch ourselves.

Our Defining Moment

Today, we stand on the threshold of a new era. Jaifry represents more than innovation; it represents hope for every parent who worries through the night and every adult living with the anxiety of the "unknown low."

Our team has worked tirelessly to develop a system that seamlessly integrates predictive AI with automated intervention. We aren't just predicting the future of diabetes care; we are delivering it today to those who need it most.

We have already seen in our clinical studies how this technology can reduce severe hypoglycemia events by more than 90%, significantly improving the quality of life for patients and their families worldwide.

Watch the Vision

Founder's Perspective

A deeper look into the "Why" behind Jaifry

My Personal Commitments

Patient Safety First

Every decision we make prioritizes patient safety above all else. Your trust is our greatest asset.

Compassionate Innovation

We will never lose sight of the human being behind the data. Our tech serves real human needs.

Ethical Leadership

We maintain the highest ethical standards from laboratory research to patient delivery.

Global Access

We are committed to making our life-saving solutions accessible to everyone, everywhere.

Our Impact In Numbers

99.2% Detection Accuracy
12 Patents Filed
$45M Funding Secured
25+ Research Partners

A Message of Gratitude

None of our progress would have been possible without the incredible team at Jaifry, our investors who believed in our mission, and the healthcare providers who guided our evolution. Most importantly, we are grateful to the patients and families who shared their stories and inspired us to push forward, even when challenges seemed insurmountable.

To our clinical trial participants: Your courage and commitment are changing the future of diabetes care. You are the true heroes of this story.

The Path Ahead

Regulatory Milestones

We are on track for FDA submission in 2025 and expect to bring Jaifry to patients by 2026. Our team works closely with authorities to ensure the highest standards.

Global Expansion

Following approval, we plan to scale into European and Asian markets, partnering with international health systems to make Jaifry available worldwide.

Continuous Innovation

Our R&D team is already developing next-gen sensors with longer wear-time, advanced AI algorithms, and seamless integration with artificial pancreas systems.

Join Us on This Journey

Whether you are a patient, healthcare provider, or investor, there is a place for you in our mission. Together, we can create a world where no one lives in fear of hypoglycemia.

Partner With Us